BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)
CAPS Rating:
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
The Official Website of the Long-Term Investor
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Great pipeline and future outlook on their own. Also a great buy-out opportunity for one of the big boys. All in all, this stock will double in the next year or so with or without a buy-out. Hang on to this one!!!